Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

ferring pharmaceuticals inc. - chorionic gonadotropin (unii: 20ed16gheb) (chorionic gonadotropin - unii:20ed16gheb) - gonadotrophin, chorionic 10000 [usp'u] - hcg has not been demonstrated to be effective adjunctive therapy in the treatment of obesity. there is no substantial evidence that it increases weight loss beyond that resulting from caloric restriction, that it causes a more attractive or "normal" distribution of fat, or that it decreases the hunger and discomfort associated with calorie-restricted diets. - prepubertal cryptorchidism not due to anatomic obstruction. in general, hcg is thought to induce testicular descent in situations when descent would have occurred at puberty. hcg thus may help to predict whether or not orchiopexy will be needed in the future. although, in some cases, descent following hcg administration is permanent, in most cases the response is temporary. therapy is usually instituted between the ages of 4 and 9. - selected cases of hypogonadotropic hypogonadism (hypogonadism secondary to a pituitary deficiency) in males. - induction of ovulation and pregnancy in the anovulatory, infertile woman in whom the cause of anovulation is seco

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - temozolomide 180mg - capsule - 180 mg - active: temozolomide 180mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - temozolomide 100mg - capsule - 100 mg - active: temozolomide 100mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - temozolomide 140mg - capsule - 140 mg - active: temozolomide 140mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - temozolomide 20mg - capsule - 20 mg - active: temozolomide 20mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - temozolomide 250mg - capsule - 250 mg - active: temozolomide 250mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - temozolomide 5mg - capsule - 5 mg - active: temozolomide 5mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid tekprint green sb-4020 titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - triclosan, quantity: 10 mg/ml - application - excipient ingredients: edetate sodium; methyl hydroxybenzoate; dibasic sodium phosphate; purified water; citric acid; ethanol; sodium lauryl sulfate; fragrance (perfume); glycerol; cocamide dea; coconut oil; diethanolamine - a foaming emolient antiseptic soap for pre-operative washing to cleanse and disinfect the skin.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - ranitidine hydrochloride -

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - hexachlorophene, quantity: 30 mg/g - lotion - excipient ingredients: sodium lauryl sulfate; citric acid; methyl hydroxybenzoate; ethanol; purified water; dibasic sodium phosphate heptahydrate; fragrance (perfume); glycerol; cocamide dea; coconut oil; diethanolamine - disinfection of skin.